Indian equity markets are indicating a weaker start on Tuesday, with early signals pointing to a cautious opening. At around 7:30 a.m., GIFT Nifty was trading 165.50 points, or 0.68%, lower at 24,052.50.
Market participants are expected to closely monitor first-quarter (Q1 FY27) corporate earnings and company-specific developments, which analysts said are likely to play a significant role in determining market direction. Geopolitical tensions in West Asia and other global regions may also influence investor sentiment and contribute to market volatility.
Several companies are scheduled to announce their Q1 financial results on Tuesday, including L&T Technology Services, Tata Elxsi, A2Z Infra Engineering, Anand Rathi Share & Stock Brokers, Aditya Birla Money, Dhampur Bio Organics, DEN Networks, Jindal Saw and SG Finserve.
HCL Technologies reported a 20.3% year-on-year increase in Q1 net profit to Rs 4,624 crore, compared with Rs 3,843 crore a year earlier. Revenue for the quarter rose 13.9% year-on-year to Rs 34,579 crore. The company's board also declared an interim dividend of Rs 12 per share for FY2027.
ICICI Prudential Asset Management Company reported a 23.1% increase in Q1 net profit to Rs 964.6 crore, while revenue rose 17.6% to Rs 1,564.2 crore. Nuvoco Vistas Corporation posted a 20% rise in net profit to Rs 159.8 crore, with revenue increasing 8.9% to Rs 3,128.7 crore.
Biocon may remain in focus after Mylan Inc. prepared to sell its entire 5.64% stake through a block deal. The transaction has a floor price of Rs 378.50 per share.
SBI Funds Management, a subsidiary of State Bank of India, has launched an initial public offering (IPO) of approximately Rs 9,813 crore. The price band has been fixed at Rs 545 to Rs 574 per share.
EMS Limited has been declared the lowest bidder (L1) for a sewerage project worth approximately Rs 105.81 crore awarded by Uttar Pradesh Jal Nigam (Urban), Varanasi.
A subsidiary of Welspun Enterprises has signed a sub-concession agreement with the Government of Maharashtra and MSIDC for the Pune-Shirur highway project valued at approximately Rs 7,300 crore.
Alembic Pharmaceuticals is also expected to remain in focus after the US Food and Drug Administration (USFDA) issued a warning letter to a clinical investigator associated with a bioequivalence study.
Grasim Industries' subsidiary, Aditya Birla Renewables, has approved the acquisition of 100% of Solenergi Power Private Limited from the Shell Group for approximately Rs 17,200 crore.
Emcure Pharmaceuticals has entered into an agreement to acquire the remaining 12.05% stake in Genova Biopharmaceuticals for approximately Rs 231.87 crore. Upon completion of the transaction, Genova will become a wholly owned subsidiary of the company.
PDS has signed a long-term "Sourcing as a Service" agreement with the global sourcing unit of a leading international supermarket group based in France. Under the agreement, the company will manage apparel sourcing operations across South Asia and Turkey.
